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Abstract
Background: Limited data exists demonstrating the efficacy of minimally invasive
surgery (MIS) compared to median sternotomy (MS) for multiple valvular disease
(MVD). This systematic review and meta‐analysis aims to compare operative and
peri‐operative outcomes of MIS vs MS in MVD.
Methods: PubMed, Ovid, and Embase were searched from inception until August
2019 for randomized and observational studies comparing MIS and MS in patients
with MVD. Clinical outcomes of intra‐ and postoperative times, reoperation for
bleeding and surgical site infection were evaluated.
Results: Five observational studies comparing 340 MIS vs 414 MS patients were
eligible for qualitative and quantitative review. The quality of evidence assessed
using the Newcastle‐Ottawa scale was good for all included studies.
Meta‐analysis demonstrated increased cardiopulmonary bypass time for MIS pa-
tients (weighted mean difference [WMD], 0.487; 95% confidence interval [CI],
0.365‐0.608; P < .0001). Similarly, aortic cross‐clamp time was longer in patients
undergoing MIS (WMD, 0.632; 95% CI, 0.509‐0.755; P < .0001). No differences were
found in operative mortality, reoperation for bleeding, surgical site infection, or
hospital stay.
Conclusions: MIS for MVD have similar short‐term outcomes compared to MS. This
adds value to the use of minimally invasive methods for multivalvular surgery, de-
spite conferring longer operative times. However, the paucity in literature and
learning curve associated with MIS warrants further evidence, ideally randomized
control trials, to support these findings.
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Abbreviations: AF, atrial fibrillation; ALT, anterolateral; AoX, aortic cross‐clamp; AV, aortic valve; CPB, cardiopulmonary bypass; ICS, intercostal space; ICU, intensive care unit;
IQR, interquartile range; MIS, minimally invasive surgery; MS, median sternotomy; MV, mitral valve; MVD, multiple valve disease; NYHA, New York Heart Association; OR, odds ratio; SD,
standard deviation; SSI, surgical site infection; TV, tricuspid valve; WMD, weighted mean difference.
1 | INTRODUCTION
Despite the wide use of minimally invasive surgery (MIS) across
multiple specialities, registry data highlights the lack of penetration
of this approach into most aspects of cardiac surgery.1 The practical
complexity and resulting steep learning curve involved in
MIS is the main factor that inhibits its use over median sternotomy
(MS).2 Nevertheless, when compared with MS, numerous studies
reviewing MIS techniques have reported benefits including reduced
morbidity, shorter hospital‐stay, improved cosmesis, and patient
satisfaction.3,4
In the field of MIS for isolated aortic valve (AV) or mitral valve
(MV) surgery, there is an accumulating body of evidence (including
randomized control trials) demonstrating its efficacy compared to
MS.5 Furthermore, it is not uncommon for patients undergoing
valvular heart surgery to have more than one disease‐afflicted
valve. This could either be as a separate disease processes or a
direct consequence (classically mitral incompetence leading to tri-
cuspid valve [TV] incompetence).6 Multiple valve disease (MVD) is
more prevalent in the elderly population.7 In the 2001 EuroHeart
Survey, more than 20% of patients with native valve disease
were found to have MVD.8 More recently, undiagnosed MVD
was identified in over 30% of participants aged ≥ 65 years in a large‐
scale echocardiographic screening programme involving 2500
participants.9
The technical challenges for treating MVD is increased
when performing procedures via smaller incisions during MIS.
Reports of acceptable outcomes of MIS for MVD have emerged
within the last two decades in smaller groups of patients. However,
high quality evidence testing the efficacy for MIS vs MS for MVD is
lacking. In this meta‐analysis of nonrandomised studies, we aim to
evaluate the outcomes of MIS compared to MS for the treatment
of MVD.
2 | MATERIALS AND METHODS
2.1 | Search methodology
An extensive literature search was conducted in accordance with
methodological recommendations by PRISMA through PubMed,
Ovid, and Embase using a search strategy including the combined
terms of: “mini” or “miniature” or “minimally” or “right” or “anterior”
AND “sternotomy” or “access” or “incision” or “thoracotomy”
AND “aorta” or “aortic” or “double valve” AND “mitral” AND
“tricuspid” from their dates of inception to August 2019 as seen in
Appendix 1.10 The studies resulting from this search were
distributed among the authors to be screened based on their titles
and abstracts for eligibility based on the objectives devised
within the predefined inclusion criteria. The reference lists of the
pertinent articles were further reviewed to identify any relevant
studies that may have not been included in the initial database
search.
2.2 | Selection criteria
Both retrospective and observational studies involving patients re-
ceiving combined MV and AV procedures with or without TV annu-
loplasty through MIS vs MS were considered. The pathophysiology of
valvular disease was not taken into consideration. The exact form of
minimal access was not restricted, but was commonly reported as a
less than or equal to 6 cm anterolateral thoracotomy (ALT) in the
third to fifth intercostal space (ICS) enabling adequate surgical ex-
posure as illustrated in Appendix 2.11 Studies were excluded if they:
1) Involved patients receiving isolated valve procedures only
2) Did not compare the two treatment modes of interest
3) Were published as case reports, editorials or commentaries
Following contemporary practice, articles were restricted to
English language and human subjects. Two reviewers (HM and MYS)
assessed all titles and abstracts for inclusion. Where a single in-
stitution published multiple cohort studies, only the largest and most
recent informative studies were included. Any disagreements be-
tween reviewers were settled by discussion and where necessary,
consensus with the senior author (HV).
2.3 | Data extraction and evaluation of quality of
evidence
Standardised data extraction forms were devised for the collection of
quantitative and qualitative data. The majority of the variables were
reported as a mean ± standard deviation (SD) or number (n) and
percentage (%). However, where data was presented as medians with
interquartile ranges (IQR, 25‐75%), we referred to the Cochrane
guidelines for expressing medians and IQR into means with SD.12 In
addition, the methodological quality of the pooled nonrandomised
studies was assessed using the Newcastle‐Ottawa scale as shown in
Appendix 3.13
2.4 | Statistical analysis
The odds ratio (OR) or weighted mean difference (WMD) were used
as the summary statistic for the incidences of short‐term complica-
tions. A random effects meta‐analysis was used to find an overall OR
comparing MIS valve surgery with MS for operative mortality due to
the expected heterogeneity between the studies. Heterogeneity was
investigated using Cochrane's test and the I2 statistic, with I2 values
interpreted according to the Cochrane collaboration.12 Funnel plots
were generated to assess for publication bias. Peter's test for small
studies was conducted to rule out large effects from potentially
nonsignificant studies. Meta‐regression analysis was used to in-
vestigate the effects of covariates, including patient and operative
characteristics. Statistical analysis was conducted using the Stata
13.0 software (Stata Corp, College Station, TX).
2 | MOHAMMED ET AL.
3 | RESULTS
3.1 | Study selection
Initially, a total of 902 studies were identified through online data-
bases with an additional 95 citations found through other sources.
After screening titles and abstracts, 30 relevant articles remained
for full‐text review against the inclusion criteria. Of these, 25 articles
were excluded on the basis of either being case reports, commen-
taries, single arm studies, animal studies or including the wrong
patient population hence, leaving five studies eligible for review.
Assessment for quality of evidence demonstrated all five studies
published between 2010 and 2019 to be of “good” quality.14‐18
Two of the studies14,18 included propensity‐matched cohorts in
their analyses, the data of which were included in our analysis in
preference over the unmatched data. The total amongst the
included studies were 340 patients in the MIS and 414 patients
in the MS group. This information is summarized in Figure 1 and
Table 1.
The characteristics of the five included studies, three of which
were retrospective and the remaining two being observational cohort
studies are demonstrated in Table 1.14‐18 Mean follow‐up time was
recorded for all five studies. A funnel plot analysis revealed little
evidence of publication bias as seen in Figure 2.
3.2 | Patient characteristics
The overall means of the patient baseline characteristics were similar
between both MIS and MS groups (Table 1). For example, age (61.2
vs 60.4 years), New York Heart Association (NYHA) functional class
≥3 (51.0% vs 51.0%), left ventricular ejection fraction (55.5% vs
55.0%), hypertension (38.8% vs 34.5%), diabetes mellitus (12.4% vs
12.8%) and atrial fibrillation (AF) (34.2% vs 34.4%). When comparing
sex in each group, the proportion of females was considerably higher
in the MS group (46.3% vs 52.0%).
3.3 | Interventions
The general indication for operation was reported as combined
valvular dysfunction among all studies. The type of surgical proce-
dures varied between studies for the MIS and MS groups as pre-
sented in Table 3, although one study failed to clearly report the
F IGURE 1 PRISMA flow chart outlining the search and study selection with reasons for exclusion provided
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specific valves that were operated on in each cohort.17 Combined AV
and MV surgery was performed in two institutions14,18 and similarly,
combined MV and TV procedures were performed at two other
centers.15,16 Three of these studies also reported operations involving
all three valves; aortic, mitral, and tricuspid (AV +MV+ TV).14,15,18 The
overall proportion of patients receiving each of these concomitant
valvular interventions was higher in the MS group among the four
studies that provided the relevant information.14‐16,18
A right ALT through the third, fourth or fifth ICS (Appendix 2)
was the approach taken in all studies.14‐18 One study also performed
a “J” incision.14 Similar cannulation techniques were reported in all
studies involving arterial perfusion achieved via the femoral artery
and venous access obtained via the femoral vein.14‐18
3.4 | Synthesis of evidence by outcome
The intra‐operative and timing outcomes of the included studies
comprising cardiopulmonary bypass (CPB) time and aortic cross‐
clamp (AoX) are shown in Table 3. The clinical and postoperative
timing outcomes of the included studies including in‐hospital mor-
tality, length of hospital and intensive care (ICU) stay, Reoperation
for bleeding, risk of stroke, surgical site infection (SSI), AF requiring
treatment and renal failure are presented in Table 4.
3.4.1 | Cardiopulmonary bypass and aortic cross‐
clamp time
CPB and AoX times were reported in all five studies (Table 3).14‐18
CPB time was found to be significantly longer in MIS patients (WMD,
0.487; 95% CI, 0.365‐0.608; P < .0001; Figure 3) Similarly, MIS pa-
tients had longer AoX times (WMD, 0.632; 95%, CI, 0.509‐0.755;
P < .0001; Figure 3) albeit with heterogeneity in the analysis.
3.4.2 | Early mortality
Early or in‐hospital mortality was reported in four studies
(Table 4).14‐16,18 Postoperative deaths occurred more frequently in
the MS group with one study reporting a greater than fivefold in-
crease in deaths of patients receiving MS compared to MIS (2% vs
11%).15 However, there was moderate heterogeneity between the
studies and minimal evidence suggesting any significant difference in
postoperative mortality between MIS and MS (OR, 0.72; 95% CI,
0.16‐3.30; P = .670; I2 = 57.5%; P = .070; Figure 4).
3.4.3 | Reoperation for bleeding
There was convincing evidence to suggest the risk of reoperation for
bleeding was higher in the MS cohort, however reoperation for



































































































































































































































































































































































































































































































































































































































































































































































































































4 | MOHAMMED ET AL.
was detected between MIS and MS cohorts in the random‐effects
model, although the high degree of statistical heterogeneity between
the studies was considerable (OR, 2.28; 95% CI, 0.78‐6.65; P = .131;
I2 = 36.5%; P = .193; Figure 4).
3.4.4 | Surgical site infection
SSI was reported in four studies and was found to be higher
amongst MS patients (Table 4).14‐16,18 No significant difference
or heterogeneity was found between MIS and MS cohorts in rates
of SSI (OR, 0.66; 95% CI, 0.18‐2.43; P = .533; I2 = 0.0%; P = .57;
Figure 5).
3.4.5 | Intensive care unit and hospital stay
Three studies reported that MS patients spent longer in ICU
(Table 4).15,17,18 There was limited evidence to suggest significant
differences between studies and no heterogeneity was detected









Age 0.32 −1.67 to 2.31 0.463 .561
Gender −3.25 −26.38 to 16.04 5.404 .621
Preoperative NYHA 3‐4 −3.50 −27.30 to 16.11 2.314 .413
Triple valve surgery 1.31 −56.06 to 63.59 4.031 .873
AV and MV only 1.72 −38.23 to 42.58 2.972 .620
Reoperation Age −0.72 −1.62 to 1.30 0.226 .180
Gender 6.36 −9.82 to 25.32 4.076 .360
Preoperative NYHA 3‐4 1.45 −15.21 to 17.56 1.760 .360
Triple valve surgery −2.68 −39.42 to 33.64 4.218 .765
AV and MV only 5.61 −48.13 to 56.32 4.734 .530
SSI Age −0.10 −1.93 to 1.74 0.426 .844
Gender 1.27 −19.10 to 21.65 4.736 .813
Preoperative NYHA 3‐4 −2.33 −45.16 to 40.50 3.371 .615
Triple valve surgery −0.30 −47.29 to 46.68 3.698 .948
AV and MV only 3.08 −37.67 to 43.83 3.207 .513
Abbreviations: AV, aortic valve; CI, confidence interval; MV, mitral valve; NYHA, New York Heart Association.
TABLE 3 Procedural and intra‐operative outcomes for the included studies in our review
Surgical procedure
References Group AV +MV MV+ TV AV +MV+ TV CPB time, min AoX time, min
Atik et ala,14 MIS 73 (90%) 8 (10%) 105 ± 32 86 ± 23
MS 72 (89%) 9 (11%) 124 ± 47 97 ± 33
Lee et al15 MIS 73 (59%) 27 (15%) 216 97 ± 36
MS 72 (58%) 16 (9%) 167 86 ± 37
Miura et al16 MIS 4 (22%) 182 107
MS 11 (39%) 177 70
Qiao et al17 MIS – – – 147 ± 41 115 ± 27
MS – – – 92 ± 23 75 ± 17
Zhao et ala,18 MIS 56 (61%) 35 (38%) 113 ± 13 80 ± 13
MS 48 (53%) 43 (47%) 104 ± 12 73 ± 12
Abbreviations: AoX, aortic cross‐clamp; AV, aortic valve; MIS, minimally invasive surgery; MS, median sternotomy; MV, mitral valve; TV, tricuspid valve;
–, no information.
aResults from propensity‐matched data.
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(OR, 2.70; 95% CI, 0.26‐5.66; P = .074; I2 = 0.0%; P = .94; Figure 6).
Furthermore, three studies reported that MS patients spent a longer
time in hospital (Table 4).16‐18 However, no strong evidence existed
to suggest differences between MIS and MS cohorts (WMD, 7.59;
95% CI, 3.78‐19.0; P = .533; I2 = 0.0%, P = .95; Figure 6).
3.5 | Meta‐regression
Due to heterogeneity present among the studies, particularly with
the variation in valves undergoing intervention, we performed meta‐
regression to investigate the effect of the variability in covariates
F IGURE 2 Funnel plot analysis with 95%
confidence interval limits. Blue circles
represent studies included in this review. The
symmetry of the blue dots suggests little or no
publication bias which may affect over‐
estimation in a meta‐analysis. SE, standard
error






stay (hours) Mortality (%)
Re‐op for







Atik et al a,14 MIS – – 5 (6.2%) 7 (8.6%) 2 (2.5%) 53 (65%) 1 (1.2%) 4 (4.9%)
MS – – 2 (2.5%) 4 (4.9%) 2 (2.5%) 48 (59%) 0 1 (1.2%)
Lee et al
201015
MIS 11 – 3 (2%) 7 (6%) 4 (3%) 22 (18%) 0 3.7 (3%)
MS 15 – 20 (11%) 5 (3%) 4 (2%) 61 (34%) 2.6 (2%) 19.8 (11%)
Miura et al
201616
MIS – 72 0 2 (11%) 0 2 (11%) 0 –
MS – 24 2 (7%) 0 0 2 (7%) 1 (0.04%) –
Qiao et al
201417
MIS 8.7 ± 4.5 45.6 ± 0.8 – – – – – –
MS 11.2 ± 5.6 67.2 ± 1.3 – – – – – –
Zhao et al
2019 a,18
MIS 6.2 ± 1.5 37.6 ± 7.3 1 (1.1%) 1 (1.1%) 1 (1.1%) 10 (11%) 1 (1.1%) 1 (1.1%)
MS 7.6 ± 1.9 48.3 ± 8.2 2 (2.2%) 2 (2.2%) 2 (2.2%) 23 (25%) 3 (3.3%) 3 (3.3%)
Abbreviarions: AF, atrial fibrillation; ITU, intensive care unit; MIS, minimally invasive surgery; MS, median sternotomy; Re‐op, reoperation;
–, no information.
aResults from propensity‐matched data.
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upon the outcomes, namely mortality, reoperation and SSI (Table 2).
All analyses found no significant influence of the rate of triple valve
surgeries, MV + AV surgeries, age or preoperative NYHA class on the
aforementioned three outcomes. This gives value to the result of the
meta‐analyses that despite study heterogeneity, there is little evi-
dence that variations in types of valve surgery or patient covariates
influenced the outcomes analysed.
4 | DISCUSSION
Minimally invasive techniques to treat isolated cardiac valve disease
have gained considerable acceptance within the last two decades due
to the accumulating body of evidence suggesting similar outcomes to
conventional sternotomy.19‐24 The additional benefits of reduced
pain and enhanced recovery are desirable for many patients which
have significant implications in the context of increasing patient‐
centred care.25 Despite the perceived advantages and the constantly
expanding aging population requiring more valvular operations, up-
take of MIS has been slow. This is especially so within the surgical
realm of double and triple valve surgery.26 This reluctance can be
partly attributed to the scant literature evaluating the outcomes of
MIS compared to MS for MVD.
In line with the results of our meta‐analysis, other studies have
also reported a general trend toward prolonged CPB and AoX times
associated with MIS when compared with MS.27‐29 Longer operative
times are known to increase the risk of renal impairment, respiratory
complications and postoperative low cardiac‐output syndrome,
(A)
(B)
F IGURE 3 Forest plot demonstrating
cardiopulmonary bypass (A) and cross‐clamp
times (B) in patients undergoing MIS vs MS
for multiple valvular procedures. Solid
squares denote OR/WMD with the size
matching the weights in meta‐analysis.
Horizontal lines represent 95% CI. The
diamond illustrates the random effects
weighted OR/WMD. The vertical black line
indicates no difference between MIS and MS.
CI, confidence interval; MIS, minimally
invasive surgery; MS, median sternotomy;
OR, odds ratio; WMD, weighted mean
difference
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especially in high‐risk patients.30‐32 However, these undesirable out-
comes were not detected in the included studies within this review.
There is no doubt that a steeper learning curve is encountered in
performing MIS for MVD.14,16 However, it has been shown that with
increasing experience, operative times are likely to significantly re-
duce in high volume centers.33 Furthermore, other operative ad-
juncts (eg, sutureless prostheses) have the potential to reduce CPB
and AoX times in MIS for MVD.34,35
One of the benefits of MIS in the literature is the reduced rate
of reoperation for bleeding although, reports are based mainly on
single valve surgeries.21,27 This may be explained by the reduced
sternal trauma and smaller incision and lesser mediastinal
dissection in MIS vs MS.31,36 This, in turn, may lead to avoidance of
transfusion‐related morbidity.37 A large‐cohort meta‐analysis
comparing mini‐sternotomy with MS for AVR (n = 4586 patients)
found that postoperative blood loss in the first 24 hours was
significantly reduced in the MIS group compared to MS.38
However, the present meta‐analysis found similar rates of re-
operation for bleeding between MIS and MS in multivalvular surgery.
Larger randomized studies would perhaps be required to assess whe-
ther the reduced bleeding offered by MIS persists for surgery in MVD.
Moreover, owing to the reduced surgical trauma, many studies
report rapid recovery as a crucial advantage of MIS including both
shorter ICU and overall hospital stay, resulting in reduced morbidity
(A)
(B)
F IGURE 4 Forest plot demonstrating early mortality (A) and reoperation for bleeding (B) in patients undergoing MIS vs MS for multiple
valvular procedures. MIS, minimally invasive surgery; MS, median sternotomy
8 | MOHAMMED ET AL.
F IGURE 5 Forest plot demonstrating
surgical site infection in patients undergoing
MIS vs MS for multiple valvular procedures
(A)
(B)
F IGURE 6 Forest plot demonstrating (A)
intensive care unit (ICU) stay and (B) hospital
stay in patients undergoing MIS vs MS for
multiple valvular procedures
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and mortality.29,39,40 This trend is consistent with our review since all
included studies apart from one14 reported reduced hospital stay for
MIS cohorts. It has been postulated that preserved sternal stability in
MIS may reduce the risk of SSI, improve respiratory function, in-
crease mobility, thus decreasing the predisposition to pneumonia and
prolonged hospital stay.31 We found no significant differences be-
tween the two surgical approaches in reducing wound infection.41‐43
However, this may be confounded by misdiagnosis accuracy and
varying definitions of SSI. Nevertheless, the clinical equivalence of-
fered by MIS is reassuring when compared to MS.
5 | LIMITATIONS
The evidence included in our meta‐analysis is based on single‐
institution, nonrandomised studies used which may be subject to
bias. These studies did not separate the outcomes from cohorts of
valve repair and valve replacement, follow‐up was limited to midterm
and none of the studies provided echocardiographic data. Further-
more, none of the studies included assessment of quality of life or
patient satisfaction as an important postoperative outcome.
6 | CONCLUSION
MIS for MVD have similar short‐term outcomes compared to MS.
This adds value to the feasibility of minimally invasive methods for
multivalvular surgery, despite conferring longer operative times.
However, the paucity in literature and learning curve associated with
MIS warrants further evidence, ideally randomized control trials, to
support these findings.
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